John Schieszer, MA

In this randomized trial, investigators sought to determine the effectiveness of high-dose dexamethasone vs conventional prednisone therapy in treatment-naïve patients with ITP. Results were presented at ASH 2017.

Recent study findings investigated the economic burden of patients with relapsed Ph-negative ALL, and the adverse events of special interest that are most likely to have the greatest impact. These findings were presented at ASH 2017.

Fosaprepitant as antiemetic prophylaxis during treatment with moderately and highly emetogenic chemotherapy appears to be safe, efficacious, and feasible in pediatric patients with hematologic malignancies who are younger than 12 years, according to results from a retrospective study. Researchers from Germany reported at the 2017 American Society of Hematology Annual Meeting (ASH 2017) that a…

Data presented at ASH 2017 confirm that ruxolitinib improves hematocrit control, hematologic remission, and reduction in spleen size in some patients with polycythemia vera who fail hydroxyurea.

Data presented at ASH 2017 illustrates the effectiveness of 2 prophylactic antiemetic regimens in pediatric patients receiving moderately or highly emetogenic chemotherapy.

Researchers evaluated the effectiveness of online learning modules on physical activity counseling for oncology nurses. Although the modules improved nurses’ counseling practices, they did not resolve the issue of physical activity in survivors.

Researchers at Memorial Sloan-Kettering Cancer Center sought to determine if observation status may be a better treatment option for older adults with cancer who present to the ED.

Nurses’ critical thinking perspective is key to recognizing and managing adverse effects in patients with lymphoma, and staying ahead of the curve in a rapidly changing clinical setting.

Study results demonstrate that statins have antitumor activity in various solid-tumor cancers and leukemia; however, experts offer these caveats on using them to treat cancer — at least for now.

Breast Cancer Awareness Month has been celebrated in October since the early 1990s. In this column, Oncology Nurse Advisor asked 3 community education advocates to share their tips for a successful awareness event.